摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-butyl-2,5-dimethylpyrrole-3,4-dicarboxyimide | 158576-88-6

中文名称
——
中文别名
——
英文名称
1-butyl-2,5-dimethylpyrrole-3,4-dicarboxyimide
英文别名
5-Butyl-4,6-dimethylpyrrolo[3,4-c]pyrrole-1,3-dione
1-butyl-2,5-dimethylpyrrole-3,4-dicarboxyimide化学式
CAS
158576-88-6
化学式
C12H16N2O2
mdl
——
分子量
220.271
InChiKey
IEUUBRUFWZPGMZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.24±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    51.1
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-butyl-2,5-dimethylpyrrole-3,4-dicarboxyimide 在 sodium hydride 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 9.0h, 生成 2-Butyl-5-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-1,3-dimethylpyrrolo[3,4-c]pyrrole-4,6-dione
    参考文献:
    名称:
    Malinka; Sieklucka-Dziuba; Rajtar, Pharmazie, 2000, vol. 55, # 1, p. 9 - 16
    摘要:
    DOI:
  • 作为产物:
    描述:
    磺酰氯 作用下, 以 为溶剂, 反应 1.0h, 以90%的产率得到1-butyl-2,5-dimethylpyrrole-3,4-dicarboxyimide
    参考文献:
    名称:
    Malinka, W.; Bodalski, T., Polish Journal of Chemistry, 1994, vol. 68, # 2, p. 297 - 308
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • COX-1/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases
    作者:Aleksandra Redzicka、Łukasz Szczukowski、Andrzej Kochel、Benita Wiatrak、Katarzyna Gębczak、Żaneta Czyżnikowska
    DOI:10.1016/j.bmc.2019.07.033
    日期:2019.9
    In the present paper we describe the biological activity of newly designed and synthesized series of pyrrolo[3,4-c]pyrrole Mannich bases (7a-n). The Mannich bases were obtained in good yields by one-pot, three-component condensation of pyrrolo[3,4-c]pyrrole scaffold (6a-c) with secondary amines and an excess of formaldehyde solution in C2H5OH. The chemical structures of the compounds were characterized
    在本文中,我们描述了新设计和合成的吡咯并[3,4-c]吡咯曼尼希碱(7a-n)系列的生物活性。曼尼希碱是通过吡咯并[3,4-c]吡咯支架(6a-c)与仲胺和过量的甲醛在C2H5OH中的溶液一锅,三组分缩合获得的。化合物的化学结构通过1 H NMR,13 C NMR,FT-IR和元素分析进行​​表征。此外,已经记录了化合物7l的单晶X射线衍射。通过比色抑制剂筛选试验研究了所有合成的衍生物抑制COX-1和COX-2酶的能力。为了分析配体与环氧合酶之间的分子间相互作用,分子对接模拟的结果为实验数据提供了支持。
  • Design, Synthesis, Biological Evaluation, and Molecular Docking Study of 4,6-Dimethyl-5-aryl/alkyl-2-[2-hydroxy-3-(4-substituted-1-piperazinyl)propyl]pyrrolo[3,4-c]pyrrole-1,3(2H,5H)-diones as Anti-Inflammatory Agents with Dual Inhibition of COX and LOX
    作者:Aleksandra Redzicka、Benita Wiatrak、Izabela Jęśkowiak-Kossakowska、Andrzej Kochel、Remigiusz Płaczek、Żaneta Czyżnikowska
    DOI:10.3390/ph16060804
    日期:——
    In the present study, we characterize the biological activity of a newly designed and synthesized series of 15 compounds 2-[2-hydroxy-3-(4-substituted-1-piperazinyl)propyl] derivatives of pyrrolo[3,4-c]pyrrole 3a–3o. The compounds were obtained with good yields of pyrrolo[3,4-c]pyrrole scaffold 2a–2c with secondary amines in C2H5OH. The chemical structures of the compounds were characterized by 1H-NMR
    在本研究中,我们表征了新设计和合成的一系列 15 种吡咯并[3,4-c]化合物 2-[2-羟基-3-(4-取代-1-哌嗪基)丙基]衍生物生物活性吡咯3a-3o。这些化合物在 C2H5OH 中与仲胺一起获得了吡咯并[3,4-c]吡咯支架 2a-2c 的高产率。通过1H-NMR、13C-NMR、FT-IR和MS对化合物的化学结构进行了表征。通过比色抑制剂筛选试验,研究了所有新化合物抑制三种酶(即 COX-1、COX-2 和 LOX)活性的效力。为了分析配体与环加氧酶/脂加氧酶之间相互作用的结构基础,实验数据得到了分子对接模拟结果的支持。
  • Malinka; Tatarczynska, Il Farmaco, 1993, vol. 48, # 7, p. 933 - 947
    作者:Malinka、Tatarczynska
    DOI:——
    日期:——
  • Synthesis and analgesic action of N-(substituted-ethyl)pyrrole-3,4-dicarboximides
    作者:W. Malinka、M. Kaczmarz、A. Redzicka、B. Filipek、J. Sapa
    DOI:10.1016/j.farmac.2004.10.002
    日期:2005.1
    We prepared a series of new N-[2-(4-substitutedpiperazin-1-yl)ethyl]-1-(n-butyl or phenyl)-2,5-dimethyl-3,4-pyrroledicarboximides 3 and the related products 4 and 5, nine representatives of which were evaluated as potential analgesic agents in an animal model (mice). The new pyrroledicarboximides were not toxic (LD50 > or = 1466 mg/kg) and eight of them displayed analgesic activity approximately 1.5-5 times superior to that of ASA in the writhing test. However, the compounds were found to be unstable in methanol solution and in dilute bases (methanol/NaOMe). The S-A relationship is discussed.
  • Synthesis and pharmacological screening of some N-(4-substituted-piperazin-1-ylalkyl)-3,4-pyrroledicarboximides
    作者:Wiesław Malinka、Maria Sieklucka-Dziuba、Grażyna Rajtar、Andrzej Rubaj、Zdzisław Kleinrok
    DOI:10.1016/s0014-827x(99)00045-2
    日期:1999.6
    As an extension of our previous work we describe the synthesis and pharmacological investigation of a new series of derivatives of pyrrole-3,4-dicarboximide possessing the 4-substitutecl-piperazin-1-ylalkyl group linked to the imide nitrogen. The products were-evaluated for acute toxicity, and effectiveness in a series of CNS and arterial blood pressure tests. The preliminary pharmacological screening was determined in animal models. Several compounds demonstrated moderate to high analgesic activity in the 'writhing syndrome' test (5f-1/640 LD50). Some of the structure-activity relationships are also discussed. (C) 1999 Elsevier Science S.A. All rights reserved.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)